An 8-week treatment course with cilostazol as an adjunct to risperidone demonstrates a favourable safety and efficacy profile in patients with schizophrenia, improving primary negative symptoms without resulting in serious adverse events requiring medical intervention, a study has shown.
Young patients receiving active attention bias modification therapy (ABMT) exhibit improved clinical benefits, a recent study has shown. In addition, ABMT appears to be most effective for patients with abnormal amygdala-insula connectivity.
There appears to be an association between patterns of reproductive lifetime exposure to oestrogen and the risk of high depressive symptoms during the menopausal transition (MT) and initial postmenopausal years, such that longer exposure to oestrogen is protective, according to a recent study.
The use of lithium treatment appears to be effective in patients with bipolar disorder with suspected suicidal intentions, according to a recent study. However, risk for suicide is only one of the many considerations when providing clinical care.
Treatment with the arginine vasopressin receptor 1A (V1a) antagonist, RG7713, induces subtle improvements in social communication surrogates including eye tracking and affective speech recognition, among others, in adults with high-functioning autism spectrum disorder (ASD), a study has shown.
The co-occurrence of mood and anxiety disorders and the existence of a family psychiatric history are associated with pharmacoresistant seizures in patients with mesial temporal lobe epilepsy (MTLE), a cross-sectional study has found.
Dr Helen Chen, head and senior consultant of the Department of Psychological Medicine at KK Women’s and Children’s Hospital (KKH) in Singapore talks about factors affecting PND and how clinicians can help their patients cope with this condition.